“…In many studies, targeting antigens to a range of DC surface molecules does not appear to require DC activation stimuli to induce strong antibody responses. These molecules include MHC class I [44] and II [20], FcgRII [44], CD45 [45], CD45RA [45], CD4 [45], CIRE [35], FIRE [35], mannose receptor [11], DCAR1 [37] and Clec9A [23,36]. In addition, low level antibody responses are often obtained even on targeting molecules such as DEC-205 that depend on adjuvants for a full response [23].…”